Searching map area
David Altshuler (physician)
? TBD
American geneticist
Join to rate
Ratings 0
Nobody has rated this yet. Be the first!
Works 15
Analysis of protein-coding genetic variation in 60,706 humans
scientific article (publication date: 17 August 2016)
The case for selection at CCR5-Delta32
scientific article published in November 2005
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk
scientific article published on 6 October 2011
Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls
article by Jason Flannick et al published 22 May 2019 in Nature
Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes
scientific article published on 13 June 2018
Methods for high-density admixture mapping of disease genes
scientific article
Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes
scientific article
Genome-wide detection and characterization of positive selection in human populations
scientific article
A second generation human haplotype map of over 3.1 million SNPs
scientific article
Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region
scientific article published in May 2004
Lists 0
Join to rate
Wikipedia

David Matthew Altshuler (born August 27, 1964) is a clinical endocrinologist and human geneticist. He is Executive Vice President, Global Research and Chief Scientific Officer at Vertex Pharmaceuticals. Prior to joining Vertex in 2014, he was at the Broad Institute of Harvard and MIT, and was a Professor of Genetics and Medicine at Harvard...

Instance of
Human
Occupation
Endocrinologist
Geneticist
References
Wikidata